Anti-TP53I13 antibodies are used in the immunodetection of the protein tumor protein p53 inducible protein 13. In humans, the canonical protein has a reported length of 393 amino acid residues and a mass of 42.2 kDa. Its subcellular localization is in the cell membrane and cytoplasm. It is found to be expressed in the heart, placenta, skeletal muscle, testis, brain and lung. TP53I13 is believed to act as a tumor suppressor. Synonyms for this target antigen include damage-stimulated cytoplasmic protein 1. TP53I13 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish and chimpanzee species. These TP53I13 antibodies are widely used in Western Blot experiments, among other applications.